The MCH(1) receptor, an anti-obesity target, is allosterically inhibited by 8-methylquinoline derivatives possessing subnanomolar binding and long residence times.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Works matching IS 00071188 AND DT 2014 AND VI 171 AND IP 5
Results: 31
1
2
Unexpectedly high affinity of a novel histamine H(3) receptor antagonist, GSK239512, in vivo in human brain, determined using PET.
- Published in:
- 2014
- By:
- Publication type:
- journal article
3
Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.
- Published in:
- 2014
- By:
- Publication type:
- journal article
4
Heterologous regulation of agonist-independent μ-opioid receptor phosphorylation by protein kinase C.
- Published in:
- 2014
- By:
- Publication type:
- journal article
5
Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats.
- Published in:
- 2014
- By:
- Publication type:
- journal article
6
The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function.
- Published in:
- 2014
- By:
- Publication type:
- journal article
7
WNT/Frizzled signalling: receptor-ligand selectivity with focus on FZD-G protein signalling and its physiological relevance: IUPHAR Review 3.
- Published in:
- 2014
- By:
- Publication type:
- journal article
8
Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization.
- Published in:
- 2014
- By:
- Publication type:
- journal article
9
Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation.
- Published in:
- 2014
- By:
- Publication type:
- journal article
10
Editorial.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
11
The MCH<sub>1</sub> receptor, an anti-obesity target, is allosterically inhibited by 8-methylquinoline derivatives possessing subnanomolar binding and long residence times.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1287, doi. 10.1111/bph.12529
- By:
- Publication type:
- Article
12
The structural role of receptor tyrosine sulfation in chemokine recognition.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1167, doi. 10.1111/bph.12455
- By:
- Publication type:
- Article
13
GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1156, doi. 10.1111/bph.12426
- By:
- Publication type:
- Article
14
Issue Information.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. i, doi. 10.1111/bph.12374
- Publication type:
- Article
15
Allosteric interactions at adenosine A<sub>1</sub> and A<sub>3</sub> receptors: new insights into the role of small molecules and receptor dimerization.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1102, doi. 10.1111/bph.12345
- By:
- Publication type:
- Article
16
Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1085, doi. 10.1111/bph.12293
- By:
- Publication type:
- Article
17
Deletion of thioredoxin-interacting protein preserves retinal neuronal function by preventing inflammation and vascular injury.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1299, doi. 10.1111/bph.12535
- By:
- Publication type:
- Article
18
Heterologous regulation of agonist-independent μ-opioid receptor phosphorylation by protein kinase C.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1330, doi. 10.1111/bph.12546
- By:
- Publication type:
- Article
19
The ryanodine receptor agonist 4-chloro-3-ethylphenol blocks ORAI store-operated channels.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1250, doi. 10.1111/bph.12528
- By:
- Publication type:
- Article
20
Role of the A<sub>2B</sub> receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1314, doi. 10.1111/bph.12539
- By:
- Publication type:
- Article
21
TLR9 and MyD88 are crucial for the maturation and activation of dendritic cells by paromomycin-miltefosine combination therapy in visceral leishmaniasis.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1260, doi. 10.1111/bph.12530
- By:
- Publication type:
- Article
22
Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1142, doi. 10.1111/bph.12420
- By:
- Publication type:
- Article
23
Unexpectedly high affinity of a novel histamine H<sub>3</sub> receptor antagonist, GSK239512, in vivo in human brain, determined using PET.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1241, doi. 10.1111/bph.12505
- By:
- Publication type:
- Article
24
Hypotensive effects of ghrelin receptor agonists mediated through a novel receptor.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1275, doi. 10.1111/bph.12527
- By:
- Publication type:
- Article
25
The GPCR, class C, group 6, subtype A ( GPRC6A) receptor: from cloning to physiological function.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1129, doi. 10.1111/bph.12365
- By:
- Publication type:
- Article
26
Biased signalling and proteinase-activated receptors ( PARs): targeting inflammatory disease.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1180, doi. 10.1111/bph.12544
- By:
- Publication type:
- Article
27
Should pharmacologists care about alternative splicing? IUPHAR Review 4.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1231, doi. 10.1111/bph.12526
- By:
- Publication type:
- Article
28
Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP- 1R activation.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1114, doi. 10.1111/bph.12313
- By:
- Publication type:
- Article
29
WNT/ Frizzled signalling: receptor-ligand selectivity with focus on FZD- G protein signalling and its physiological relevance: IUPHAR Review 3.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1195, doi. 10.1111/bph.12364
- By:
- Publication type:
- Article
30
Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1210, doi. 10.1111/bph.12489
- By:
- Publication type:
- Article
31
The evolving small-molecule fluorescent-conjugate toolbox for Class A GPCRs.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 5, p. 1073, doi. 10.1111/bph.12265
- By:
- Publication type:
- Article